Brainstorm Cell Therapeutics (BCLI) Current Assets (2010 - 2026)
Brainstorm Cell Therapeutics (BCLI) reported Current Assets of $316,000 for Q2 2026, down 79.1% from $1.52 million a year earlier but up 71.7% from the prior quarter.
Brainstorm Cell Therapeutics (BCLI) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Brainstorm Cell Therapeutics posted Current Assets of $307,000, down 20.3% from FY2024.
- Current Assets has declined for five consecutive years, with a five-year compound annual growth rate of -62.8% (FY2020 to FY2025).
- By year, Current Assets came in at $385,000 in FY2024 (-79.7%), $1.9 million in FY2023 (-38.9%), $3.11 million in FY2022 (-86.7%) and $23.28 million in FY2021 (-46.2%).
- Five-year quarterly Current Assets spans a low of $184,000 in Q1 2026 and a high of $27.94 million in Q3 2021.
- Year over year, Current Assets has now declined in each of the last three quarters, with an average decline of 35.4% over the last eight quarters.
- The high point for year-over-year Current Assets in five years was Q2 2024 (growth of 214.6%); the low point was Q1 2026 (a decline of 92.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $184,000 (Q1 2026), $307,000 (Q4 2025) and $508,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Brainstorm Cell Therapeutics | 8.50 Mn | 8.43 Mn | - | 316,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 316,000.00 |
| Mar 31, 2026 | 184,000.00 |
| Dec 31, 2025 | 307,000.00 |
| Sep 30, 2025 | 508,000.00 |
| Jun 30, 2025 | 1.52 Mn |
| Mar 31, 2025 | 2.33 Mn |
| Dec 31, 2024 | 385,000.00 |
| Sep 30, 2024 | 364,000.00 |
| Jun 30, 2024 | 3.82 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 1.90 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 2.93 Mn |
| Dec 31, 2022 | 3.11 Mn |
| Sep 30, 2022 | 7.50 Mn |
| Jun 30, 2022 | 12.81 Mn |
| Mar 31, 2022 | 19.26 Mn |
| Dec 31, 2021 | 23.28 Mn |
| Sep 30, 2021 | 27.94 Mn |
Brainstorm Cell Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=BCLI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();